HIV-infected adolescents in southern Africa can achieve good treatment outcomes: Results from a retrospective cohort study

AIDS

Volumn 27, Issue 12, 2013, Pages 1971-1978

  Shroufi, Amir ^a   Gunguwo, Hilary ^b,c   Dixon, Mark ^b,c   Nyathi, Mary ^b,c   Ndebele, Wedu ^b,c   Saint Sauveur, Jean François ^a   Taziwa, Fabian ^a   Ferreyra, Cecilia ^a   Viñoles, Mari Carmen ^a   Ferrand, Rashida A ^d  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Mpilo OI ART Clinic   (Greece)

^c NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Zimbabwe)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Adolescent; Adolescent friendly services; AIDS; Antiretroviral; Antiretroviral therapy; Cohort study; HIV; Zimbabwe

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; ZIMBABWE;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-HIV AGENTS; CHILD; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; ZIMBABWE;

EID: 84884415177     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32836149ea     Document Type: Article

References (34)

1. Halperin DT, Mugurungi O, Hallett TB, Muchini B, Campbell B, Magure T, et al. Asurprising prevention success:why did the HIV epidemic decline in Zimbabwe? PLoS Med 2011; 8:e1000414.
2. Ferrand RA, Corbett EL, Wood R, Hargrove J, Ndhlovu CE, Cowan FM, et al. AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS 2009; 23:2039-2046.
3. Ferrand R, Lowe S, Whande B, Munaiwa L, Langhaug L, Cowan F, et al. Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count? Bull World Health Organ 2010; 88:428-434.
4. World Health Organisation 2. WHO antiretroviral therapy of HIV in infants and children in resource limited settings, toward universal access. Geneva, Switzerland: WHO.
5. Sawyer SM, Drew S, Yeo MS, Britto MT. Adolescents with a chronic condition: challenges living, challenges treating. Lancet 2007; 369:1481-1489.
6. Markowitz M, Saag M, Powderly WG, Hurley AM, Hsu A, Valdes JM, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995; 333:1534-1539.
7. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr 2009; 51:65-71.
8. Bakanda C, Birungi J, Mwesigwa R, Nachega JB, Chan K, Palmer A, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PloS One 2011; 6:e19261.
9. Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR, et al. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 2005; 159:764-770.
10. Belzer ME, Fuchs DN, Luftman GS, Tucker DJ. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health 1999; 25:316-319.
11. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Adolescent Medicine HIV/AIDS Research Network. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care 2001; 13:27-40.
12. Flynn PM, Rudy BJ, Lindsey JC, Douglas SD, Lathey J, Spector SA, et al. Long-term observation of adolescents initiating HAART therapy: three-year follow-up. AIDS Res Hum Retroviruses 2007; 23:1208-1214.
13. World Health Organisation. WHO Anthos (version 3.2.2.) and Macros [Internet]. 2011. Available from: http://www.who.int/childgrowth/publications/ en/. [Accessed 5 April 2012].
14. Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PloS One 2009; 4:e5790.
15. World Health Organisation. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach (2006 revision). Geneva, Switzerland: WHO; 2010.
16. Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, Amani-Bosse C, et al. Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa. Trop Med Int Health 2010; 15 (Suppl 1):34-42.
17. Nglazi MD, Lawn SD, Kaplan R, Kranzer K, Orrell C, Wood R, et al. Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa. J Acquir Immune Defic Syndr 2011; 56:e1-e8.
18. Nglazi MD, Kranzer K, Holele P, Kaplan R, Mark D, Jaspan H, et al. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infect Dis 2012; 12:21.
19. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 2010; 15 (Suppl 1):1-5.
20. Ferrand RA, Bandason T, Musvaire P, Larke N, Nathoo K, Mujuru H, et al. Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey. PLoS Med 2010; 7:e1000178.
21. Feucht UD, Kinzer M, Kruger M. Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children. J Trop Pediatr 2007; 53:398-402.
22. Wilfert C, Aronson JE, Beck DT, Fleischman AR, Kline MW, Mofenson LM, et al. Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999. Pediatrics 1999; 103:509-511.
23. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011; 365:1471-1481.
24. Braitstein P, Boulle A, Nash D, Brinkhof MWG, Dabis F, Laurent C, et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) 2008; 17:47-55.
25. Chen SCC, Yu JKL, Harries AD, Bong CN, Kolola-Dzimadzi R, Tok TS, et al. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Trop Med Int Health 2008; 13:513-519.
26. Logistics Management Information Systems. Zimbabwean Ministry of Health and Child Welfare. Request, submitted to AIDS and TB Unit, MoHCW Zimbabwe, by MSF on 2 May 2012.
27. Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, et al. Association of ongoing drug and alcohol use with nonadherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care 2011; 23:775-785.
28. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR, et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med 2003; 157:249-255.
29. Buchanan AL, Montepiedra G, Sirois PA, Kammerer B, Garvie PA, Storm DS, et al. Barriers to medication adherence in HIVinfected children and youth based on self- and caregiver report. Pediatrics 2012; 129:e1244-e1251.
30. Chandwani S, Koenig LJ, Sill AM, Abramowitz S, Conner LC, D'Angelo L. Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIV. J Adolesc Health 2012; 51:242-251.
31. Messer LC, Pence BW, Whetten K, Whetten R, Thielman N, O'Donnell K, et al. Prevalence and predictors of HIV-related stigma among institutional- and community-based caregivers of orphans and vulnerable children living in five less-wealthy countries. BMC Public Health 2010; 10:504.
32. Kang M, Dunbar M, Laver S, Padian N. Maternal versus paternal orphans and HIV/STI risk among adolescent girls in Zimbabwe. AIDS Care 2008; 20:214-217.
33. Brinkhof MWG, Spycher BD, Yiannoutsos C, Weigel R, Wood R, Messou E, et al. Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. PloS One 2010; 5:e14149.
34. Gray GE. Adolescent HIV: cause for concern in Southern Africa. PLoS Med 2010; 7:e1000227.